Axcelis Technologies, Inc. (NASDAQ: ACLS) announced that its stockholders have approved all proposals related to the pending merger with Veeco Instruments Inc. (NASDAQ: VECO) at a special meeting. The completion of the merger is subject to customary closing conditions, including final regulatory approval from the State Administration for Market Regulation of the People’s Republic of China. Both companies expect the merger to be completed in the second half of 2026.
In connection with the proposed merger, Axcelis filed a registration statement with the Securities and Exchange Commission (SEC) on Form S-4, which was declared effective on December 31, 2025. Axcelis and Veeco also filed a definitive joint proxy statement/prospectus with the SEC on December 31, 2025.
The company's stockholders will be provided with the final voting results of the special meeting in a Form 8-K to be filed with the SEC. The details of the voting results will shed light on the level of support from Axcelis' shareholders for the proposed merger.
Axcelis, headquartered in Beverly, Massachusetts, has been providing innovative solutions for the semiconductor industry for over 45 years. The company is focused on developing enabling process applications through the design, manufacture, and complete life cycle support of ion implantation systems, which are critical in the IC manufacturing process.
Investors and security holders are urged to carefully review the joint proxy statement/prospectus and any other relevant documents filed with or furnished to the SEC, as they contain important information about the proposed merger and related matters.
The completion of the merger is eagerly anticipated, and the finalization of the regulatory approval from China remains a significant milestone for the companies involved. Once completed, the consolidated entity will likely undergo significant changes in its financial metrics and operational dynamics, which could have a material impact on the semiconductor industry. Today the company's shares have moved -3.5% to a price of $93.12. Check out the company's full 8-K submission here.
